3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
NIH
34
OTHER
13
NETWORK
7
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Interventions
pembrolizumab
152
Carboplatin
116
Cisplatin
70
Paclitaxel
68
Pemetrexed
65
Gemcitabine
63
Bevacizumab
59
Docetaxel
48
Fluorouracil
46
Oxaliplatin
45
Dexamethasone
44
durvalumab
35
Leucovorin
35
Capecitabine
33
Rituximab
32
atezolizumab
30
Lenalidomide
30
Fulvestrant
30
Injections
29
Cyclophosphamide
29
Prednisone
28
Nivolumab
27
Letrozole
26
Cetuximab
26
130-nm albumin-bound paclitaxel
26
venetoclax
24
pomalidomide
24
enzalutamide
22
Irinotecan
21
daratumumab
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
X-Rays
×
30 days
×
Clear all
NCT07581184
2026-05-12
BActinium-1
Aktis Oncology, Inc.
Phase 1
Recruiting
138 enrolled